IceCure Medical Ltd ICCM · NASDAQ
$1.00 -7.41% (-$0.08)
Summary
43 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $12.0M against $90.0K.
- The price moves less than the market (beta 0.43).
What to watch
- The company made a loss over the last 12 months.
- It missed profit estimates 6 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 3.7% a year over 5 years. Over the last 3 years it grew by 3.1% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $16.9M.
Profitability in detailIs it financially healthy?
YesOver the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 3
- Hold 0
- Sell 0
Today's price within the analysts' price targets
The average target of $1 is at today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
The company reports no revenue by product.
By region
- Other Countries Member 57%
- UNITED STATES 27%
- JAPAN 8.3%
- INDIA 3.6%
- CHINA 3.2%
- Other 0.7%
Other Countries Member brings in 57% of revenue. UNITED STATES grew fastest, by 15% a year.
Segments in detail